Solid Biosciences Inc. (SLDB:NASDAQ) closed at $6.30 on November 3, 2026, up 4.92% on the day. The stock trades 45.0% below its 52-week high of $11.45 and 66.1% above its 52-week low of $3.79. Over the past year, it gained 15.4%. Solid Biosciences Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since October 31, 2025, SLDB closed higher on 123 days (49%). Its best day was March 6, 2026 (+20.32%) and its worst was November 4, 2025 (-15.29%). The stock moved 10% or more in a single session 13 times.
Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
Find more stocks like SLDB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.